Johnson & Johnson requires claims data on every 340B dispense and extends its contract-pharmacy policy to grantees on November 3

Healthcare Dive reported on September 14, 2026 that Johnson & Johnson began requiring 340B providers to submit claims data for each of its drugs dispensed or administered in order to keep receiving upfront 340B discounts, effective September 15, 2026. The article states the policy "applies to all 340B providers, including hospitals and community health centers, except for those in HIV/AIDS programs," that providers have up to 45 days for most drugs to submit the documentation, and that if providers fail to comply J&J "could suspend their access to all 340B discounts."

It separately reports a contract-pharmacy restriction — described in the article in terms of hospitals receiving 340B pricing at only one contract pharmacy within 40 miles of the parent site — with an effective date of November 3 for grantees. This record rests on trade reporting, not on J&J's own policy document, which was not obtained; the article's 20% to 50% savings range is stated for hospitals and is not an FQHC figure; and the article does not spell out how the 40-mile contract-pharmacy limit applies to a Section 330 grantee's sites, so treat the November 3 grantee date as the verified fact and the operative mechanics as unconfirmed.